146 related articles for article (PubMed ID: 6726962)
21. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.
Stamey TA; Kabalin JN; Ferrari M
J Urol; 1989 May; 141(5):1084-7. PubMed ID: 2468796
[TBL] [Abstract][Full Text] [Related]
22. Prostatic acid phosphatase as measured with two radioimmunoassay kits in the detection of prostatic adenocarcinoma.
Brody JP; Savory J; Sturgill BC; Lehman MR; Wills MR
Clin Chem; 1981 Apr; 27(4):605-7. PubMed ID: 7471429
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
Aleyassine H; MacIsaac SG
Clin Biochem; 1980 Jun; 13(3):109-12. PubMed ID: 7418193
[TBL] [Abstract][Full Text] [Related]
24. Discordance between concentrations of prostate-specific antigen and acid phosphatase in serum of patients with adenocarcinoma of the prostate.
Beaver TR; Schultz AL; Fink LM; Andersen CA; Donohue RE
Clin Chem; 1988 Jul; 34(7):1524. PubMed ID: 2455612
[No Abstract] [Full Text] [Related]
25. The value of serum prostate specific antigen determinations before and after radical prostatectomy.
Lange PH; Ercole CJ; Lightner DJ; Fraley EE; Vessella R
J Urol; 1989 Apr; 141(4):873-9. PubMed ID: 2467013
[TBL] [Abstract][Full Text] [Related]
26. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
[TBL] [Abstract][Full Text] [Related]
27. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
Vihko P; Kostama A; Jänne O; Sajanti E; Vihko R
Clin Chem; 1980 Oct; 26(11):1544-7. PubMed ID: 6158382
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Canal P; Soula G
Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
[TBL] [Abstract][Full Text] [Related]
29. A solid phase radioimmunoassay for prostatic acid phosphatase.
Cooper JF; Foti A; Herschman HH; Finkle W
J Urol; 1978 Mar; 119(3):388-91. PubMed ID: 642096
[TBL] [Abstract][Full Text] [Related]
30. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
Vihko P; Lukkarinen O; Kontturi M; Vihko R
Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
[TBL] [Abstract][Full Text] [Related]
31. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Foti AG; Cooper JF; Herschman H; Malvaez RR
N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
[TBL] [Abstract][Full Text] [Related]
32. The effects of various manipulations on serum phosphatase levels in benign disease.
Greene FT; Thompson IM
J Urol; 1974 Aug; 112(2):232-6. PubMed ID: 4135604
[No Abstract] [Full Text] [Related]
33. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology.
Panteghini M; Pagani F; Bonora R
Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):135-9. PubMed ID: 1376155
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
Samuell CT; Morgans BT; O'Donoghue EP
Br J Urol; 1984 Apr; 56(2):208-12. PubMed ID: 6498440
[TBL] [Abstract][Full Text] [Related]
36. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
Perrin P; Clairet F; Fleury-Goyon MC; Durand L
J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
[TBL] [Abstract][Full Text] [Related]
37. The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy.
Carlton JC; Zagars GK; Oswald MJ
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1383-8. PubMed ID: 2262362
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
Stamey TA; Kabalin JN
J Urol; 1989 May; 141(5):1070-5. PubMed ID: 2468794
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
Pontes JE; Choe BK; Rose NR; Ercole C; Pierce JM
J Urol; 1981 Sep; 126(3):363-5. PubMed ID: 6168779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
